Neurocrine Bioscienc
(NBIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,800 | -102,100 | 21,100 | 3,033 | -47,731 |
| Depreciation Amortization | 13,400 | 6,500 | 22,900 | 18,214 | 12,000 |
| Accounts receivable | -39,100 | -15,700 | -25,100 | -23,436 | -11,519 |
| Other Working Capital | -21,300 | -30,800 | -1,700 | -14,655 | -13,586 |
| Other Operating Activity | 49,500 | 29,600 | 84,200 | 67,754 | 42,829 |
| Operating Cash Flow | $-48,300 | $-112,500 | $101,400 | $50,910 | $-18,007 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 49,100 | -171,000 | -218,100 | -329,289 | N/A |
| PPE Investments | -8,400 | -3,900 | -24,800 | -18,772 | -6,413 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -224,076 |
| Sale Of Investment | N/A | 215,900 | N/A | 211,402 | 138,925 |
| Investing Cash Flow | $40,700 | $41,000 | $-242,900 | $-136,659 | $-91,564 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,900 | 2,600 | 29,500 | 27,748 | 22,258 |
| Financing Cash Flow | $6,900 | $2,600 | $29,500 | $27,748 | $22,258 |
| Beginning Cash Position | 147,200 | 147,200 | 259,200 | 259,212 | 259,212 |
| End Cash Position | 146,500 | 78,300 | 147,200 | 201,211 | 171,899 |
| Net Cash Flow | $-700 | $-68,900 | $-112,000 | $-58,001 | $-87,313 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,300 | -112,500 | 101,400 | 50,910 | -18,007 |
| Capital Expenditure | -8,400 | -3,900 | -24,800 | -18,802 | -6,443 |
| Free Cash Flow | -56,700 | -116,400 | 76,600 | 32,108 | -24,450 |